IV Fluids and Medications: Connecting Coding, Coverage, and Compliance

Medicare contractor audits often result in partial denials because documentation does not adequately support the medical necessity of IV fluids and IV medications. Facilities have expressed concern that omitting these treatments from the MDS could result in a citation under F641, Accuracy of Assessment.

Accurate MDS coding and documentation of medical necessity, however, are separate responsibilities. The MDS serves purposes beyond reimbursement, and coding a treatment alone does not establish that the treatment was clinically appropriate or medically necessary.

Facilities should not omit coding a treatment solely because of concern about a Medicare denial. Instead, they should determine whether the treatment meets the applicable MDS coding criteria and whether the medical record supports both the coding and the resident-specific need for the treatment.

Connecting Care, Coding, Coverage, and Compliance

The RAI Manual, Medicare Benefit Policy Manual, and State Operations Manual are separate resources, but they don't exist in a vacuum. Together, they support resident care, accurate assessment, appropriate Medicare coverage, and regulatory compliance.

The resident's condition and individual needs guide treatment decisions, consistent with accepted standards of practice and applicable regulatory requirements described in the State Operations Manual, Appendix PP. Treatments are coded on the MDS when they meet the applicable item-specific criteria, look-back periods, and coding instructions in the RAI Manual. The Medicare Benefit Policy Manual establishes requirements for Medicare Part A coverage, including whether services are reasonable and necessary.

Medicare Part A: Establishing Medical Necessity

The Medicare Benefit Policy Manual, Chapter 8, §30, explains that skilled services must be reasonable and necessary to treat the patient's illness or injury. Services must be consistent with the nature and severity of the condition, the individual's particular medical needs, and accepted standards of medical practice.

Section 30.2.2.1, Documentation to Support Skilled Care Determinations, explains that the medical record must contain sufficient information for a reviewer to determine whether the services provided meet these requirements.

A resident's Medicare Part A coverage depends on meeting the applicable requirements for a covered SNF stay, including the need for daily skilled care. The presence of an IV treatment on the MDS does not, by itself, establish that the stay meets Medicare coverage requirements or that the treatment supports the payment classification billed. For IV fluids and medications, the medical record should clearly establish the resident-specific reason for treatment, the expected benefit, the treatment provided, and the resident's response. A general statement that treatment is intended to avoid rehospitalization does not, by itself, establish medical necessity.

IV Medications: Documenting Clinical Indication

The State Operations Manual, Appendix PP, provides interpretive guidance to surveyors regarding the requirements for medication use in nursing facilities. This guidance reinforces the importance of documenting the clinical indication for medications, including those administered intravenously.

F757 — Drug Regimen Is Free from Unnecessary Drugs

Under 42 CFR §483.45(d), an unnecessary drug includes a medication used without adequate indications for its use. The medical record should support the clinical indication for the medication and provide sufficient information to evaluate its use for the individual resident.

The Unnecessary Medications, Psychotropic Medications, and Medication Regimen Review Critical Element Pathway directs surveyors, during the record review, to consider whether documentation of the resident's conditions or symptoms supports the need for the medication.

IV Iron: Explaining the Treatment and Route

For example, IV iron infusions, such as Venofer^®, have been partially denied when documentation did not adequately support the treatment.

The FDA-approved indication for Venofer^® is iron deficiency anemia in patients with chronic kidney disease. Use outside that indication should be evaluated against applicable Medicare coverage requirements and supporting clinical evidence. Off-label use is not automatically inappropriate or noncovered; FDA-approved indications and Medicare coverage are related but distinct considerations. The medical record should explain the resident-specific clinical rationale for the treatment and the IV route, including consideration of alternatives when relevant.

Documentation should connect the treatment decision to the resident's assessment, clinical condition, and therapeutic goals.

IV Fluids: Supporting the Need for Hydration

The RAI Manual includes specific instructions for coding parenteral/IV feeding at MDS item K0520A. Facilities should review the applicable coding criteria and ensure the record supports the fluids' purpose, including when they are needed for nutrition or hydration.

The clinical record should also explain the resident-specific need for IV hydration. Depending on the circumstances, relevant documentation may include the resident's oral intake, interventions attempted, and the clinical reasons oral fluids alone were insufficient or inappropriate.

General references to poor oral intake, frailty, or advanced age, without further assessment and clinical rationale, may not adequately explain why IV fluids were necessary for that individual resident.

F694 — Parenteral Fluids

Appendix PP's guidance at F694 addresses parenteral fluids and IV therapy. As part of the investigation, surveyors review the resident's medical record and care plan to determine whether documentation supports the need for IV therapy, among other considerations.

Hydration Critical Element Pathway

The Hydration Critical Element Pathway prompts surveyors to consider factors such as:

• 
  

• Interventions: What has the facility done to address a resident's refusal to drink; for example, offering liquids in a different form?

• 
  

• Laboratory findings: Do laboratory values suggest dehydration?

• 
  

• Clinical signs and circumstances: Has the resident experienced potential indicators of a hydration deficit, such as reduced fluid intake, vomiting, diarrhea, lethargy, dizziness, or an acute illness?

These questions can also help the interdisciplinary team identify assessment findings and interventions to document in the resident's medical record.

Key Takeaway: Code Accurately and Document the Need

Accurate MDS coding, Medicare coverage, and regulatory compliance are connected, but each has its own requirements. Code IV fluids and medications according to the applicable RAI Manual criteria and ensure the medical record supports the resident-specific clinical need, the treatment provided, and the resident's response.

Together, these elements support accurate MDS coding, Medicare coverage, and regulatory compliance.

Alicia Cantinieri, MBA, BSN, RN, CHC, RAC-MT, RAC-CTA, DNS-CT, QCP, is the chief reimbursement-compliance officer, Zimmet Healthcare Services Group.

Comments or question? Contact Patrick Connole at pconnole@parkplacelive.com.